Home › Abbvie 'Enhanzes' Halozyme Therapeutics coffers in potential $1.193B collaboration
 

Keywords :   


Abbvie 'Enhanzes' Halozyme Therapeutics coffers in potential $1.193B collaboration

2015-06-04 06:37:32| Logistics - Topix.net

Fresh off reporting good news at the American Society of Clinical Oncology annual meeting in Chicago, Halozyme Therapeutics Inc. segued into yet another global collaboration and license agreement - this time with Abbvie Inc. - that could add $1.193 billion to its coffers. The deal allows Abbvie, of North Chicago, to apply Halozyme's Enhanze delivery platform to up to nine of its compounds in return for $23 million up front to Halozyme and milestone payments totaling approximately $130 million for each collaboration target.

Tags: potential collaboration therapeutics coffers

Category:Transportation and Logistics

Latest from this category

All news
24.11Eastern North Pacific Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Atlantic Tropical Weather Outlook
24.11Eastern North Pacific Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
23.11Eastern North Pacific Tropical Weather Outlook
23.11Atlantic Tropical Weather Outlook
Transportation and Logistics »
24.115 2 PG
24.11215103TW 17svtw
24.11 Switch light
24.11Dr.SLUMP 19
24.11layover LP
24.11PING i230 6W 5
24.11BTS CD
24.11HG 56
More »